Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000
Summary
Medicare Part D is a bold experiment in the public/private provision of health insurance. Both researchers and beneficiaries need access to data to see if it works, but the government is stonewalling, according to Dana Goldman and Daniel McFadden.Recommended Citation
Goldman, Dana P. and McFadden, Daniel L.
(2008)
"Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000,"
The Economists' Voice:
Vol. 5
:
Iss.
4, Article 1.
DOI: 10.2202/1553-3832.1375
Available at: http://www.bepress.com/ev/vol5/iss4/art1
